SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol
Background: Six million Americans suffer from atrial fibrillation (AF), a heart rhythm abnormality that significantly increases the risk of stroke. AF is responsible for 15% of ischemic strokes, which lead to permanent disability in 60% of cases and death in up to 20%. Anticoagulation (AC) is the ma...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Cardiovascular Digital Health Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666693621000591 |
id |
doaj-10fe455e3c904ae59edd7df2194597e9 |
---|---|
record_format |
Article |
spelling |
doaj-10fe455e3c904ae59edd7df2194597e92021-08-14T04:31:57ZengElsevierCardiovascular Digital Health Journal2666-69362021-08-0124222230SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocolJay Patel, BS0Hammad Sadiq, BS1John Catanzaro, MD, FHRS2Sybil Crawford, PhD3Adam Wright, PhD4Gordon Manning, MD5Jeroan Allison, MD, MSc6Kathleen Mazor, EdD7David McManus, MD, MSc, FHRS8Alok Kapoor, MD, MSc9Department of Medicine, University of Massachusetts Medical School, Worcester, MassachusettsDepartment of Medicine, University of Massachusetts Medical School, Worcester, MassachusettsDepartment of Medicine, University of Florida College of Medicine, Jacksonville, FloridaDepartment of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts; Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester, MassachusettsDepartment of Biomedical Informatics, University of Vanderbilt School of Medicine, Nashville, TennesseeDepartment of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts; University of Massachusetts Memorial Health Care, Worcester, MassachusettsUniversity of Massachusetts Memorial Health Care, Worcester, Massachusetts; Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MassachusettsDepartment of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts; University of Massachusetts Memorial Health Care, Worcester, Massachusetts; Meyers Primary Care Institute, A Joint Endeavor of University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, Worcester, MassachusettsDepartment of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts; University of Massachusetts Memorial Health Care, Worcester, MassachusettsDepartment of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts; University of Massachusetts Memorial Health Care, Worcester, Massachusetts; Address reprint requests and correspondence: Dr Alok Kapoor, Biotech One, Suite 100, University of Massachusetts Medical School, 365 Plantation St, Worcester, MA 01605.Background: Six million Americans suffer from atrial fibrillation (AF), a heart rhythm abnormality that significantly increases the risk of stroke. AF is responsible for 15% of ischemic strokes, which lead to permanent disability in 60% of cases and death in up to 20%. Anticoagulation (AC) is the mainstay for stroke prevention in patients with AF. Despite guidelines recommending AC for patients, up to half of eligible patients are not on AC. Clinical decision support tools in the electronic health record (EHR) can help bridge the disparity in AC prescription for patients with AF. Objective: To enhance and assess the effectiveness of our previous rule-based alert on AC initiation and persistence in a diverse patient population from UMass-Memorial Medical Center and University of Florida at Jacksonville. Methods/Results: Using the EHR, we will track AC initiation and persistence. We will interview both patients and providers to determine a measure of satisfaction with AC management. We will track digital crumbs to better understand the alert’s mechanism of effect and further add enhancements. These enhancements will be used to refine the alert and aid in developing an implementation toolkit to facilitate use of the alert at other health systems. Conclusion: If the number of AC starts, the likelihood of persisting on AC, and the frequency alert use are found to be higher among intervention vs control providers, we believe such findings will confirm our hypothesis on the effectiveness of our alert.http://www.sciencedirect.com/science/article/pii/S2666693621000591AnticoagulationAtrial fibrillationClinical decision supportClinical trialsElectronic medical records |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jay Patel, BS Hammad Sadiq, BS John Catanzaro, MD, FHRS Sybil Crawford, PhD Adam Wright, PhD Gordon Manning, MD Jeroan Allison, MD, MSc Kathleen Mazor, EdD David McManus, MD, MSc, FHRS Alok Kapoor, MD, MSc |
spellingShingle |
Jay Patel, BS Hammad Sadiq, BS John Catanzaro, MD, FHRS Sybil Crawford, PhD Adam Wright, PhD Gordon Manning, MD Jeroan Allison, MD, MSc Kathleen Mazor, EdD David McManus, MD, MSc, FHRS Alok Kapoor, MD, MSc SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol Cardiovascular Digital Health Journal Anticoagulation Atrial fibrillation Clinical decision support Clinical trials Electronic medical records |
author_facet |
Jay Patel, BS Hammad Sadiq, BS John Catanzaro, MD, FHRS Sybil Crawford, PhD Adam Wright, PhD Gordon Manning, MD Jeroan Allison, MD, MSc Kathleen Mazor, EdD David McManus, MD, MSc, FHRS Alok Kapoor, MD, MSc |
author_sort |
Jay Patel, BS |
title |
SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol |
title_short |
SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol |
title_full |
SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol |
title_fullStr |
SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol |
title_full_unstemmed |
SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol |
title_sort |
support-af iv: supporting use of ac through provider prompting about oral anticoagulation therapy for af clinical trial study protocol |
publisher |
Elsevier |
series |
Cardiovascular Digital Health Journal |
issn |
2666-6936 |
publishDate |
2021-08-01 |
description |
Background: Six million Americans suffer from atrial fibrillation (AF), a heart rhythm abnormality that significantly increases the risk of stroke. AF is responsible for 15% of ischemic strokes, which lead to permanent disability in 60% of cases and death in up to 20%. Anticoagulation (AC) is the mainstay for stroke prevention in patients with AF. Despite guidelines recommending AC for patients, up to half of eligible patients are not on AC. Clinical decision support tools in the electronic health record (EHR) can help bridge the disparity in AC prescription for patients with AF. Objective: To enhance and assess the effectiveness of our previous rule-based alert on AC initiation and persistence in a diverse patient population from UMass-Memorial Medical Center and University of Florida at Jacksonville. Methods/Results: Using the EHR, we will track AC initiation and persistence. We will interview both patients and providers to determine a measure of satisfaction with AC management. We will track digital crumbs to better understand the alert’s mechanism of effect and further add enhancements. These enhancements will be used to refine the alert and aid in developing an implementation toolkit to facilitate use of the alert at other health systems. Conclusion: If the number of AC starts, the likelihood of persisting on AC, and the frequency alert use are found to be higher among intervention vs control providers, we believe such findings will confirm our hypothesis on the effectiveness of our alert. |
topic |
Anticoagulation Atrial fibrillation Clinical decision support Clinical trials Electronic medical records |
url |
http://www.sciencedirect.com/science/article/pii/S2666693621000591 |
work_keys_str_mv |
AT jaypatelbs supportafivsupportinguseofacthroughproviderpromptingaboutoralanticoagulationtherapyforafclinicaltrialstudyprotocol AT hammadsadiqbs supportafivsupportinguseofacthroughproviderpromptingaboutoralanticoagulationtherapyforafclinicaltrialstudyprotocol AT johncatanzaromdfhrs supportafivsupportinguseofacthroughproviderpromptingaboutoralanticoagulationtherapyforafclinicaltrialstudyprotocol AT sybilcrawfordphd supportafivsupportinguseofacthroughproviderpromptingaboutoralanticoagulationtherapyforafclinicaltrialstudyprotocol AT adamwrightphd supportafivsupportinguseofacthroughproviderpromptingaboutoralanticoagulationtherapyforafclinicaltrialstudyprotocol AT gordonmanningmd supportafivsupportinguseofacthroughproviderpromptingaboutoralanticoagulationtherapyforafclinicaltrialstudyprotocol AT jeroanallisonmdmsc supportafivsupportinguseofacthroughproviderpromptingaboutoralanticoagulationtherapyforafclinicaltrialstudyprotocol AT kathleenmazoredd supportafivsupportinguseofacthroughproviderpromptingaboutoralanticoagulationtherapyforafclinicaltrialstudyprotocol AT davidmcmanusmdmscfhrs supportafivsupportinguseofacthroughproviderpromptingaboutoralanticoagulationtherapyforafclinicaltrialstudyprotocol AT alokkapoormdmsc supportafivsupportinguseofacthroughproviderpromptingaboutoralanticoagulationtherapyforafclinicaltrialstudyprotocol |
_version_ |
1721207608873844736 |